| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.632 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.632 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
0.632 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
0.632 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
0.632 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.632 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.632 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.632 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.632 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.632 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.632 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
0.632 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.632 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.632 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.632 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
0.632 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
0.632 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.632 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.632 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.632 |
Evidence |
|
| SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
0.632 |
Evidence |
|
| ICAM1 |
ICAM1: Intercellular adhesion molecule 1 precursor |
VIL2 |
IPI00479359 |
0.632 |
Evidence |
O
|
| IL6 |
IL6, IFNB2: Interleukin-6 precursor |
IL9R |
IL9R: Interleukin-9 receptor precursor |
0.632 |
Evidence |
|
| IL6 |
IL6, IFNB2: Interleukin-6 precursor |
MPL |
MPL, TPOR: Thrombopoietin receptor precursor |
0.632 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
0.632 |
Evidence |
|